Fueling Precision Medicine: From Sequence to Therapeutics

We are on the precipice of the next major shift in science as it relates to medicine. The 20th Century saw an explosion of technological advances that reshaped modern life completely. Today, the surge of discoveries and development continues particularly in biology. It is very possible that our counter arts in the future may look back on the 21st century as the Century of Biology.

 

A look at precision medicine

Precision medicine is the ability to understand and treat disease at a molecular level and it is driving revolutionary change in fields such as oncology. It aims to improve therapeutic outcomes by adding a previously missing but critical factor – the unique biology of the patient being incorporated into the treatment equation. This is done by including DNA sequence information.

According to the U.S. Food and Drug Administration, “Precision medicine, sometimes known as “personalised medicine” is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people’s genes, environments, and lifestyles. The goal of precision medicine is to target the right treatments to the right patients at the right time.”

Based on this foundation, one megatrend to keep an eye on is cellular manufacturing. This is the ability to reprogram cells for practical purposes and it is transforming industrial biotechnology. Many chemicals and materials traditionally produced through petrochemical processes are now the products of engineered biological cells. Cellular manufacturing also requires a deep understanding of cellular metabolism and pathway interdependencies which are being accelerated by the vast amount of metabolomic information becoming available through advancements in mass spectrometry.

Although mass spectrometry is not new, its application in the clinical realm is fairly recent by medical research standards. For over half a century, diagnostics relied on immunoassays but mass spectrometry is addressing many of the limitations of immunoassays and also becoming vitally important to precision medicine. The high accuracy and sensitivity of mass spectrometric analysis of proteomes are suited for the incorporation of proteomics into precision medicine. Mass spectrometry can provide an understanding of how a patient reacts and interacts with a drug. With new instruments now able to easily fit on a benchtop and deliver results accurately at remarkable speeds with lower costs, it’s become the perfect test for precision medicine patient management.

 

A key example of megatrend impact: Cardiovascular disease

Inroads are being made in the treatment of cardiovascular disease through sequencing of the PCSK9 gene where it was discovered that various mutations of this gene are associated with high low-density lipoproteins (LDL) cholesterol levels a factor in multiple diseases. The knowledge that this gene plays a role—that high LDL levels weren’t simply a matter of poor diet—has contributed to the development of inclisiran, a small or short interfering RNA (siRNA) therapeutic that acts to silence the PCSK9 gene and effect clinically significant reductions in LDL cholesterol levels. Sequencing and mass spectrometry are essential to identify which patients have mutations in the PCSK9 gene to identify candidates for inclisiran therapy.

 

The future: Predicting biology

The megatrends of precision medicine and cellular manufacturing share a common driver: the past 20 years have seen a marked shift in our ability to understand and characterise biology as a primarily qualitative science to one that is increasingly quantitative. This shift carries the promise of eventually allowing us to understand, model and predict biology in the same way that we are able to do in the physical sciences—an exceptionally complex proposition that lies beyond our current capabilities. At a fundamental level, as our capacity to understand and control biology at the molecular level deepens our understanding of disease fuels parallel advances in industrial biotechnology.

This article was originally published by Agilent and has been amended here.

 

Analysis of Permanent Gases: More Challenging Than You Might Think

Permanent gases such as carbon monoxide, CO2, O2, N2, and methane are common in refinery gases, natural gas, fuel cell gases, and many other industrial processes. Permanent gas analysis finds wide application in the fields of petrochemical, chemical, and energy industries.

On the surface, this would appear to be a simple separation—however, there are several challenges related to the analysis of permanent gases. This webinar will discuss typical techniques for resolving and detecting permanent gases, including carbon dioxide and hydrogen. Other topics will include cryogenic techniques, column isolation, and the use of the Agilent J&W Select Permanent Gases/CO2 GC column.

 

Speaker

Mark Sinnott
Application Engineer
Agilent Technologies, Inc.

Mark Sinnott works for Agilent Technologies as a Technical Support Engineer in the Consumables and Supplies Division (CSD). In his position at Agilent, Mark performs technical support and applications assistance to gas chromatographers worldwide. He has more than 22 years of experience in gas chromatography, including environmental analysis of compounds in air, soil and water matrices, including dissolved gas analysis for the electrical industry. Mark holds a Master’s Degree in Chemistry from California State University, Sacramento, and currently resides in Twin Falls Idaho.

 

Register and watch on demand >

 

Addressing Data Integrity Gaps: Does Your Lab Have a Strategy?

Data integrity is paramount in today’s digital world. Data Integrity Insights helps your lab stand up to any regulatory examination by informing you about the latest global enforcement trends and the strategies you can use to stay compliant. Presenting uncompromised results and maintaining compliance with the latest regulations and standards, including those issued by the pharmaceutical, environmental and food regulatory bodies, is a necessity.

The traditional approaches to laboratory data integrity are insufficient to meet today’s increased scrutiny of computerised systems and the terabytes of data they produce. To successfully present your results, you must be prepared to prove that your data have not been compromised—and that can be a challenge.

Does your lab have a data integrity strategy? Are data integrity gaps putting your company at risk?

Learn how to perform data process mapping on a chromatographic process from the set-up of analysis through calculating the reportable result. From this map, the data integrity gaps can be identified, and the risk assessed to determine how critical the gaps are so that a plan and strategy to remediate or remove the risks can be implemented.

 

What you will learn

  • Understand the scope of a data integrity program
  • How to perform data process mapping on a chromatographic process to identify data integrity gaps, assess the risk posed by those gaps, and determine how to remediate or solve them.
  • Understand options for short-term remediation and long-term solutions

 

Who should attend

Analytical chemists, technicians, laboratory managers, regulatory affairs personnel and others working in R&D and QA/QC in the pharmaceutical industry.

 

Bob McDowall
Director, RD McDowall
Limited, Bromley,
Kent, UK

Register and watch on demand >

 

Industrialising High-Throughput Glycoproteomics Using AI for Clinical Use

Cancer is a leading cause of death worldwide and there is a great movement globally to develop new treatments and advance how cancer is diagnosed. Technology has been a great help, particularly in recent years, and now there’s new innovation that could take our cancer diagnosis and treatment to a new level.

According to an article published by The Guardian, doctors, scientists and researchers have built an artificial intelligence model that can accurately identify cancer in a development they say could speed up diagnosis of the disease and fast-track patients to treatment. This is but one of many new developments that include AI technology in cancer diagnosis as well as treatment.

In this webinar, we learn the predictive powers of artificial intelligence combined with cutting-edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome. This presentation is for all who are interested to learn more about the real-world clinical application of glycoproteomics on cancer diagnosis.

 

Speaker

Dr. Low Ley Hian
Director of Development
InterVenn Biosciences

 

Register and watch on demand >

 

Gather Assay Materials

Energy metabolism drives cell function in health and disease. The landscape of therapeutic discovery is rapidly evolving, and cellular metabolism has emerged as the critical driver of a range of common diseases. Cell biology functions as a network of signaling, pathways, and checkpoints — with cellular metabolism as a central orchestrator to fuel many cellular processes.

The development of safe and effective drugs requires an understanding of genes, proteins, and pathways that may be key intermediates and potential candidates for drug target intervention. Cellular processes are dynamic, and metabolic programs are the upstream determinants of cellular outcomes. Identification and validation of potential drug targets requires a comprehensive view of those upstream drivers to modulate cell response and safely and effectively intervene.

Agilent Seahorse XF technology provides functional, live-cell metabolic measurements for a more direct measure and a deeper understanding of cellular processes. In this training webinar, you will learn about the fundamentals of Agilent Seahorse XF technology, the typical XF assay workflow, the Agilent XF Assay Learning Center resource, and the required and recommended materials to perform a successful XF assay.

 

Register and watch on demand >

 

Join us at analytica Lab Africa 2023

analytica Lab Africa is the premier trade fair for the analysis, laboratory-technology and biotechnology sectors, bringing together scientists, entrepreneurs and users from around the world. Welcome to the perfect platform for your international business relations.

Chemetrix will be taking part in this prestigious event to showcase some of our latest instruments, innovations and partnerships.

 

Why you should visit

The international trade fair analytica Lab Africa focuses on innovative and applied product and system solutions for laboratories in the industrial, research and science sectors. As the industry’s regional forum for Southern Africa, analytica Lab Africa combines global and local market leaders and innovations with country specific main themes, precisely tailored to the market.

 

A global network

analytica gives you access to the world’s largest network of trade fairs for laboratory technology, analysis and biotechnology. Open the door to global success for your company. Present your products and solutions to the markets of the future.Germany, China, India, South Africa and Vietnam.

 

Exciting innovations

Get new and deeper insights into the Agilent product and solution portfolio with Agilent InterAct! Experience your favourite Agilent system in a virtual 3D environment. Visit our stand at the event for the exclusive launch of an immersive experience like never before.

 

Event details

Gallagher Convention Centre is one of Africa’s largest conference and exhibition venues. Located in Midrand, between Pretoria and Johannesburg, Gallagher is conveniently positioned in the business hub of Gauteng.

 

Show Dates

5-7 July, 2023

Venue

Gallagher Convention Center, Johannesburg, South Africa

Opening Hours

Wednesday, 5th July, 0900 hrs – 1700 hrs

Thursday, 6th July, 0900 hrs – 1700 hrs

Friday, 7th July, 0900 hrs – 1600 hrs

 

Register to attend the event >

 

We look forward to connecting with you an analytical Lab Africa 2023

 

Food and Cannabis Elemental Analysis Part 2: Elemental Sample Prep for the Food and Agriculture Lab – Optimizing Your System for High Matrix Samples

Trace elemental analysis of foods and cannabis products is essential to ensure that products are suitable for consumption. The analysis of minerals and additional trace elements is also important because it provides labelling information that is required when these products are used as nutritional.

Agilent has presented a webinar series that focuses on elemental sample preparation to optimise high matrix samples in the food and agriculture testing space.

 

Part 1

We will cover the entire Agilent elemental portfolio. Each of the different instruments’ strengths and how they meet the challenges that food and cannabis labs have.

 

Part 2

We will focus on preparing your samples, including microwave digestion. We will also cover how to optimize your system for high matrix samples and a diverse sample set.

 

Part 3

We will put it all together, with running samples live in the lab. We will also share additional tips and tricks for obtaining excellent analytical results in these difficult matrices.

This focused information on spectroscopy applications is valuable for the emerging cannabis market as well as analysts who are seeking to master skills for food testing.

 

Speakers

Jenny Nelson, PhD
Application Scientist
Agilent Technologies, Inc.

Jenny Nelson received her Ph.D. in Analytical Chemistry from the University of Cincinnati in 2007, and her MBA from Saint Mary’s College of California in 2011. Currently, Jenny is an Application Scientist for the Life Science and Chemical Analysis team at Agilent Technologies, joining in 2012 (with a step away in 2019). Jenny is also an Adjunct Professor in the Department of Viticulture and Enology at the University of California, Davis, since 2013. Jenny has been very active with AOAC and ASTM over the past eight years, serving on expert review panels, chairing committees, and volunteering to develop new methods needed by the industry. Jenny has extensive experience in operating and method development for Inductively Coupled Plasma Mass Spectroscopy (ICP-MS), Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES), Microwave Plasma Atomic Emission Spectroscopy (MP-AES). Jenny has broad knowledge and experience in different speciation analysis for many sample matrices using GC-ICPMS and LC-ICPMS. As well as vast experience with sp-ICP-MS for many applications.

 

Greg Gilleland
Application Scientist
Agilent Technologies, Inc.

Greg began his spectroscopy career in 1987 in Colorado, working at a series of environmental labs. After 14 years working in the world of commercial environmental labs, he moved on to a spectroscopy instrument manufacturer where he performed service and sales functions over the course of 11 years. He has been with Agilent Technologies, Inc., since 2012 in the role of Application Scientist for ICP-OES, MP-AES and AA products.

 

Mark Kelinske
Application Scientist
Agilent Technologies, Inc.

Mark Kelinske is an Applications Chemist with Agilent Technologies, specializing in advanced ICP-MS and ICP-MS/MS techniques. He received his undergraduate and graduate degrees from Texas A&M University in College Station, TX. Prior to Agilent, Mark was a senior research scientist and research group manager with Southern Research Institute in Birmingham, AL, where he focused on low-level analytical chemistry, method development, and research program management.

 

Chris Conklin
Atomic Spectroscopy Product Specialist
Agilent Technologies, Inc.

With a degree from the University of Wisconsin – Eau Claire, Chris worked in, and lead, a quality control lab testing fine chemicals ranging from reagent grade to high purity. Over the course of 12 years in that role, Chris has run a variety of atomic elemental instruments and techniques including AA, ICP-OES, and ICP-MS. As a result, he has seen most of the periodic table in its elemental form and overcome the associated interferences. In 2018, Chris brought that knowledge and experience to his current role with Agilent as the Product Specialist for Atomic Spectroscopy supporting AA, MP-AES, and ICP-OES for the Eastern US.

 

Register and watch on demand >

 

Fingerprinting Honey to Ensure Purity

How pure is that honey in your jar?

Although there’s a rising demand for honey, the honey bee population is also under threat. Another not-so-sweet issue is the number of products labelled as honey on retail shelves that don’t meet the criteria to be classified as pure honey.

The term “adulterated honey” means any honey to which has been added honeydew, glucose, dextrose, molasses, sugar, sugar syrup, inverted sugar, or any other similar product or products other than the nectar of floral exudations of plants gathered and stored in the comb by honey bees.

Food fraud is a significant concern for consumers and producers, with research indicating that fraud accounts for up to 25% of all globally reported food safety incidents. The growing demand for food authenticity means consumers regularly pay a premium for organic and sustainably produced goods like honey. Fraudsters have been flooding markets with adulterated, low-quality, or mislabeled foodstuffs, damaging the livelihoods of legitimate businesses and potentially risking consumer health.

 

Increasing demand

Consumers have become quite specific in their demand for honey, focusing on unifloral honey or monofloral honey obtained predominantly from bees that feed on a single species of plant flowers. This results in a unique colour, flavour, and fragrance exclusive to each type of unifloral honey. As consumers are willing to pay more for these products, protections must ensure that they purchase what they expect.

According to data from the Food and Agriculture Organization of the United Nations, China, Mexico, Russia, Turkey, and the United States are among the major honey-producing countries accounting for approximately 55 per cent of world production. The most common form of adulteration involves extending or diluting honey with other less expensive sweeteners. Commonly identified extenders are corn, cane, and beet syrups.

 

Testing for authenticity to mitigate honey fraud

Global e-commerce is placing honey sales outside regulatory oversight more frequently—a trend expected to continue. This, combined with increased fraudulent activities, makes tackling the problem critical. This is why it is important to identify these substances quickly, efficiently, and consistently. The food industry requires analytical instruments and testing techniques to consistently and rapidly analyze food and identify trace chemicals.

Analytical testing is essential for assessing food authenticity, which is important to protect consumers’ health, the brand, and producers’ income. Testing is a necessary part of an overall strategy to mitigate fraud risk, and methods for authenticity testing are rapidly evolving, with innovative technologies now available for developing robust food testing techniques.


Agilent 1290 Infinity II LC System

For example, it has been demonstrated in recent years that coupling high-performance liquid chromatography with quadrupole time-of-flight (LC/Q-TOF), such as the Agilent 1290 Infinity II LC System with Agilent 6545 LC/Q-TOF, provides a sensitive method to reveal the chemical composition of honey samples. Using this method with a non-targeted approach enables the identification of new types and sources of fraud through the chemical markers in the honey, highlighting which kind of fraudulent activity is occurring. Since this technique evaluates multiple markers in honey to determine authenticity, it is very difficult for fraudsters to cheat by adding one or a few adulterants. This innovative technique is called honey fingerprinting.


Agilent 6545 LC/Q-TOF

 

Determining honey’s unique chemical composition

Honey fingerprinting is the practice of using a suitable technique to record as much information as possible on the chemical composition of a particular honey sample. In the same way, a human fingerprint is unique to individuals, this fingerprinting method unlocks and records the unique molecular composition of authentic honey samples. This enables the mapping of food components in an unprecedented fashion that will revolutionize how honey is regulated for quality, safety, and authenticity.

Utilizing a non-targeted workflow begins with identifying other compounds, including pesticides, molecules that indicate freshness, like a compound called HMF (which suggests thermal processing or age if present in high numbers), and phenolic compounds, which are related to the floral origin of honey. The advantage of using LC/Q-TOF for this technique is its efficiency: higher molecular/trace information levels can be obtained from just one sample in less time versus targeted methods focusing on just a few parameters.

 

Standardising honey fingerprinting methods

Although previous work has been done developing case studies for fingerprinting foodstuffs, including honey, the approaches among laboratories have been different regarding sample preparation and instrumental condition. There are also differences in terms of data processing and analysis. As a result, two laboratories analyzing the same sample may obtain slightly different results. Ideally, developing a standardized fingerprinting method that could be used across all LC/MS-based workflows, enabling the same testing technique to be used across multiple laboratories, would be optimal and where future work is aimed.

When addressing the issues of food safety, product quality, and authenticity, each may be governed by separate sets of regulations. For example, looking at the residues of contaminants in honey, such as pesticides, there may be differences globally. Countries may have their own restrictions for the maximum limit for specific compounds. Contaminants are a part of the picture when considering fingerprinting for honey, but permitted levels may vary between countries.

Additionally, as samples come from the field to the lab for testing, there is potential interest in reversing this and bringing the lab out into the field instead. This interesting but not yet recognised capability would enable regulators and the global food industry to respond more quickly to honey contamination and food fraud.

 

Taking a global approach to ensure honey purity

As the food supply chain becomes increasingly globalized, raising the opportunity for food fraud, experts predict that testing, such as those described above, will become more accessible, increasingly automated, and easier to perform. Fingerprinting methods—in which the entire molecular profile of food can be obtained—will be a feature of future fraud prevention and identification systems.

A positive step forward is the focus on building a library of authentic honey samples and making it an accessible, open database so that honey fingerprinting information is available across multiple stakeholders in the global supply chain. With increased knowledge, more scientists will be able to adopt techniques such as LC/Q-TOF and could also use this testing for other types of food—for example, maple syrup.

The ultimate goal is for food testing laboratories to confidently measure contaminants that threaten the global food chain and tackle food fraud head-on to ensure that consumers can access authentic and safe honey.

(This article has been modified from its original appearance on the Agilent website)

Accelerating Drug Development, QC & Manufacturing

During this webinar we will describe the newest breakthrough technologies and applications of Raman, Laser based Infrared and UV-Vis Spectroscopy in Pharma.

This will include use of transmission Raman as an alternative to UPHPLC for content uniformity and polymorph studies. Furthermore, use of a next generation IR instrument using a quantum cascade laser will be described for chemical imaging studies including analysis of tablet component distribution, polymorph distribution, salt exchange and stability studies. New breakthrough technologies for ultra-fast and productive parallel temperature based kinetic studies, protein folding, DNA melting and other temperature related UV-Vis measurements will end this overview.

 

Jan Wülfken
Product Specialist – Molecular Spectroscopy
Agilent Technologies

Dr. Wuelfken has worked for many years as Product Specialist for Agilent Technolgies in many region of the world, supporting Molecular ( Raman FTIR, Fluorescence nad UV-Vis/NIR) Spectroscopy business.

 

Register and watch on demand >

 

Raw Material Identification Through All Kinds of Package Materials

In this webinar we will focus on raw material identification and will give a detailed comparison about the different spectroscopic techniques FTIR, NIR and Raman as well as an a new special Raman way called “SORS” to measure though opaque containers.

Jan Wülfken
Product Specialist – Molecular Spectroscopy
Agilent Technologies

Dr. Wuelfken has worked for many years as Product Specialist for Agilent Technolgies in many region of the world, supporting Molecular ( Raman FTIR, Fluorescence nad UV-Vis/NIR) Spectroscopy business.

 

Register and watch on demand >